Alloy Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: midlife women who want menopause-trained doctors and a choice of brand or compounded GLP-1s
Alloy falls below our bar on disclosure. It charges from $169 a month; its compounded tirzepatide, at $199, is 26% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Alloy is a menopause care company, and its Weight Care program prescribes brand and compounded GLP-1 drugs to women in midlife. On the brand side it offers Zepbound, the Foundayo pill, and Wegovy as a pen or a pill; compounded semaglutide, tirzepatide and liraglutide are also offered. Every option carries a $99 monthly care fee on top of the drug, so compounded semaglutide comes to $169 a month. Code STARTGLP1 takes $50 off the first month's fee.
Is Alloy legit?
Yes. Alloy is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.0/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an Alloy promo or coupon code?
Alloy publishes the code STARTGLP1 ($50 off your first month of Alloy Weight Care for new customers; $99/mo first month becomes $49). You enter it at checkout on Alloy's own site. Other codes for Alloy circulate on coupon sites, and we cannot vouch for those.
See how Alloy compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Alloy
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
AgelessRx
Best for: microdosed compounded GLP-1s from a longevity clinic, or brand Wegovy at manufacturer pricing plus monitoring
Editorial score · methodology
Alloy at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Liraglutide, Wegovy, Zepbound
- Starting price
- $169/mo
- Availability
- 48 states + DC
- FDA status
- No FDA warning letters found
How Alloy scores
Six columns, each one computed from something Alloy has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.2/10$199/month is 26% below the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses liraglutide, orforglipron, semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
9.7/10Serves 48 of 50 states and DC.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Alloy
Last checked October 2026- Checked the listed price across 7 dose or plan tiers
- Checked state coverage: 48 states
- Checked FDA warning letters for Alloy
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Alloy involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Alloy shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Alloy which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $169, tirzepatide $199, liraglutide $214. That leaves out membership fees, first-month rates and insurance copays.
- Alloy serves 48 of 50 states and DC, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Alloy
- Phone
- 1-888-660-1816
- Alloy offers email support
- Hours
- Mon-Fri 8am-8pm ET, Sat-Sun 10am-7pm ET
Medications Alloy lists
Alloy lists Wegovy, Zepbound, Foundayo, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
$70 medication (1-month supply) plus the mandatory $99/mo Alloy Weight Care fee = $169/mo effective
$100 medication (1-month supply) plus the mandatory $99/mo Alloy Weight Care fee = $199/mo effective
$115 medication (1-month supply) plus the mandatory $99/mo Alloy Weight Care fee = $214/mo effective
Wegovy pen shown as starting at $199, struck from $499, plus the mandatory $99/mo Alloy Weight Care fee; $298/mo effective at the $199 start. The drug is paid to NovoCare, which ships it.
Wegovy pill starting at $149 for a 1-month supply plus the mandatory $99/mo Alloy Weight Care fee = $248/mo effective at the starting price.
Zepbound starting at $299 plus the mandatory $99/mo Alloy Weight Care fee = $398/mo effective. The drug is paid to LillyDirect, which ships it.
Foundayo (orforglipron) pill starting at $149 for a 1-month supply plus the mandatory $99/mo Alloy Weight Care fee = $248/mo effective. The self-pay price is paid to LillyDirect, which ships it.
Check the price yourself before you pay
Every figure here comes from Alloy's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $169 a month, 15% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $199 a month, 26% below the $269 median for compounded tirzepatide across the sellers we compare
- Serves 48 states and DC
- We found no FDA warning letters issued to Alloy
Against it
- Liraglutide costs $214 a month, 34% above the $160 median for compounded liraglutide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its compounded liraglutide, semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Alloy charges
Alloy lists $169/month.
- Compounded semaglutide: $169/month
- Compounded tirzepatide: $199/month
- Compounded liraglutide: $214/month
- Wegovy pen: $298/month
- Wegovy pill: $248/month
- Zepbound: $398/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Alloy's $199 is genuinely below the middle, not just advertised that way. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
MEDGm, at about $169/month, is the closest like-for-like alternative we review.
What Alloy dispenses
Alloy prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Alloy at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot. The Wegovy pill is priced by dose; what it costs each way you can pay compares the routes.
Safety and disclosure
Alloy tells you the 48 states it serves. We found no FDA warning letters issued to Alloy. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Alloy will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Alloy bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- injections are the thing keeping you from starting
Our read
Alloy competes on price: $199/month for compounded tirzepatide. The catch is disclosure, which is why Alloy scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
Alloy falls below our bar on disclosure. It charges from $169 a month; its compounded tirzepatide, at $199, is 26% below the $269 median among the sellers we compare.
Before you pay Alloy
Starting at $169 a month. Check today's price, then start the intake.
Where Alloy is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Alloy sets more sellers in the same category beside Alloy on price, states and what the price includes.
Frequently Asked Questions
How to check Alloy yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: District of Columbia, Massachusetts, Nevada, New Hampshire, New Mexico, Pennsylvania, Virginia, West Virginia and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Alloy review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Alloy's current pricing
Plans start at $169 a month. Whether you qualify is a clinician's decision, made after your intake.